About This Page
This is a clinician-written, evidence-based summary aligned to the USMLE Step 2 CK Content Outline. It is intended for medical students preparing for USMLE Step 2 CK. Management reflects current ACC/AHA, USPSTF, and APA guidelines. Always cross-reference with UpToDate, institutional protocols, and clinical judgment.
The Bottom Line
- Pre-travel visit should review destination, season, duration, activities, accommodations, medical problems, pregnancy, immune status, and vaccine history
- Update routine vaccines first: MMR, varicella, influenza, COVID, Tdap, polio, hepatitis A/B as indicated
- Destination-specific vaccines include typhoid, yellow fever, Japanese encephalitis, meningococcal, cholera, rabies pre-exposure, and tick-borne encephalitis where relevant
- Malaria prophylaxis depends on destination resistance and patient factors: atovaquone-proguanil, doxycycline, mefloquine, chloroquine where sensitive, or tafenoquine with G6PD testing
- Travelers diarrhea prevention centers on food/water precautions; self-treatment often uses azithromycin for severe diarrhea or dysentery
- Yellow fever vaccine is live; avoid in severe immunosuppression and assess age, thymus disease, pregnancy, and allergy risks
Overview
Travel medicine is preventive infectious diseases care tailored to itinerary and host risk. The CDC Yellow Book approach prioritizes routine immunization, destination-specific vaccines, malaria prophylaxis, food and water safety, insect precautions, animal bite prevention, sexual health, injury prevention, and plans for illness abroad. For examinations, the most tested areas are malaria prophylaxis selection, yellow fever vaccine contraindications, rabies post-exposure management, typhoid vaccination, and travelers diarrhea treatment.
Epidemiology
US travelers commonly acquire travelers diarrhea, respiratory infections, skin infections, dengue, malaria, influenza, hepatitis A, typhoid, and sexually transmitted infections. Risk is highest for travelers visiting friends and relatives, long stays, rural travel, adventure travel, humanitarian or health care work, immunocompromised travelers, pregnancy, and poor access to medical care.
Clinical Features
Symptoms
Pre-travel assessment is preventive; ask about itinerary, rural exposure, altitude, freshwater, animals, health care work, and sexual exposure
Fever during or after travel is malaria until proven otherwise if destination is endemic
Bloody diarrhea, fever, or severe travelers diarrhea may need antibiotics and evaluation
Animal bite or bat exposure requires urgent rabies risk assessment
Jaundice after travel suggests hepatitis, malaria, leptospirosis, yellow fever, or hemolysis
Pregnancy or immunosuppression changes vaccine and prophylaxis choices
Signs
Pre-travel exam often normal; focus on risk assessment and vaccine contraindications
Post-travel fever with splenomegaly or jaundice suggests malaria or systemic infection
Rash with fever after travel suggests dengue, chikungunya, Zika, rickettsioses, measles, or meningococcemia
Neurologic signs after animal exposure raise rabies or encephalitis concerns
Dehydration signs in travelers diarrhea guide oral versus IV rehydration
Investigations
First-line
Itinerary-specific risk reviewCountries, regions, urban/rural, season, duration, accommodations, activities, and outbreak alerts determine prevention
Immunization record reviewRoutine vaccines first; identify live vaccine contraindications
Pregnancy test when relevantPregnancy affects malaria prophylaxis, live vaccines, Zika counseling, and antibiotic choices
Second-line
G6PD testingRequired before primaquine or tafenoquine malaria prophylaxis or radical cure
Post-travel malaria smearsAny fever after endemic travel warrants thick/thin smears repeated if negative
Stool testingIf persistent, bloody, febrile, outbreak-associated, or immunocompromised travelers diarrhea
Specialist
Travel clinic / infectious diseases consultationComplex itineraries, immunocompromise, pregnancy, organ transplant, uncertain yellow fever exemption, or severe post-travel illness
Public health reportingSuspected viral hemorrhagic fever, measles, polio, cholera, malaria, or other reportable diseases
Management
CDC Yellow Book 20261
Vaccines
- Routine: MMR, varicella, Tdap, influenza, COVID, polio, pneumococcal when indicated
- Hepatitis A for many international travelers; hepatitis B for sexual exposure, health care work, long stay, or general risk
- Typhoid oral live attenuated or injectable polysaccharide for risk destinations; neither is fully protective
- Yellow fever vaccine for endemic areas or entry requirements; provide International Certificate or medical waiver if contraindicated
- Rabies pre-exposure vaccine for high-risk animal exposure, remote travel, veterinarians, cavers, or long stays
2
Malaria prophylaxis
- Atovaquone-proguanil: start 1-2 days before travel, daily during, 7 days after; avoid in severe renal impairment
- Doxycycline: start 1-2 days before, daily during, 4 weeks after; photosensitivity/esophagitis; avoid in pregnancy
- Mefloquine: weekly, start at least 2 weeks before, continue 4 weeks after; avoid in seizure or major psychiatric disorder
- Chloroquine: only where chloroquine-sensitive; weekly, start 1-2 weeks before and continue 4 weeks after
- Tafenoquine: weekly option requiring quantitative G6PD testing; avoid in pregnancy and G6PD deficiency
3
Travelers diarrhea
- Oral rehydration is first-line
- Bismuth subsalicylate can reduce risk but avoid with aspirin allergy, anticoagulation, renal disease, or pregnancy
- Standby antibiotics: azithromycin preferred for dysentery, febrile diarrhea, or regions with fluoroquinolone-resistant Campylobacter
- Avoid loperamide with fever or bloody diarrhea unless paired with appropriate antibiotic and clinically suitable
4
Bites and exposures
- Animal bite: immediate wound washing; assess rabies PEP with vaccine plus human rabies immune globulin if not previously vaccinated
- Avoid freshwater exposure in schistosomiasis areas; use insect precautions for dengue, Zika, chikungunya, malaria, and rickettsioses
- Counsel on condoms, PrEP/PEP access, injury prevention, altitude illness prevention, and travel insurance/evacuation planning
Complications
- Severe malaria: Most important preventable fatal travel infection
- Rabies: Nearly universally fatal after symptom onset; PEP is urgent
- Yellow fever vaccine adverse events: Rare but serious viscerotropic or neurologic disease, especially in older adults/thymus disease
- Dehydration: Travelers diarrhea can cause AKI and hospitalization
- Congenital infection: Zika and malaria are major pregnancy concerns
USMLE Step 2 CK Exam Tips
- 1Fever after travel to malaria area = malaria testing regardless of prophylaxis
- 2Atovaquone-proguanil continues 7 days after travel; doxycycline and mefloquine continue 4 weeks after travel
- 3Mefloquine is contraindicated with seizure disorder or significant psychiatric disease
- 4Yellow fever vaccine is live; avoid in severe immunosuppression and consider waiver if contraindicated
- 5Rabies PEP in unvaccinated patient = wound cleaning + HRIG + vaccine series
- 6Severe travelers diarrhea or dysentery = azithromycin is the usual exam answer
- 7Typhoid vaccination reduces but does not eliminate risk; food/water precautions still matter
practicetest your knowledge on travel medicine & prophylaxisApply what you've learnt with USMLE Step 2 CK-style questions from the iatroX Q-Bank — infectious diseases and beyond.
open q-bank